Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opioid Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00228605
What this trial is testing

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

Who this might be right for
Low Back PainMigraineDiabetic Neuropathies+1 more
Cephalon 500
Early research (Phase 1)Study completedNCT02712554
What this trial is testing

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

Who this might be right for
PainNauseaVomiting
Charleston Laboratories, Inc 40
Not applicableStudy completedNCT04139564
What this trial is testing

EaseVRx for the Reduction of Chronic Pain and Opioid Use

Who this might be right for
Chronic Low-back Pain
AppliedVR Inc. 108
Large-scale testing (Phase 3)Study completedNCT01240863
What this trial is testing

Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time

Who this might be right for
Chronic Pain
Teva Branded Pharmaceutical Products R&D, Inc. 391
Large-scale testing (Phase 3)Study completedNCT01789970
What this trial is testing

Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain

Who this might be right for
Low Back Pain
Teva Branded Pharmaceutical Products R&D, Inc. 625
Not applicableEnded earlyNCT01694199
What this trial is testing

Pulsed Radiofrequency Energy to Treat Post-Bunionectomy Pain

Who this might be right for
Post-operative Pain
Regenesis Biomedical, Inc. 139
Large-scale testing (Phase 3)Study completedNCT00936884
What this trial is testing

Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation

Who this might be right for
Constipation
Bausch Health Americas, Inc. 50
Early research (Phase 1)Looking for participantsNCT07325279
What this trial is testing

Nalmefene Implant in Healthy Subjects

Who this might be right for
Opioid Abuse and Addiction
ReacX Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01738503
What this trial is testing

Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects

Who this might be right for
Opioid Related Disorder
Indivior Inc. 124
Not applicableStudy completedNCT04340622
What this trial is testing

Efficacy And Safety Of An Innovative Treatment Of Opiate Use Disorders

Who this might be right for
Opioid-use DisorderOpioid DependenceOpioid Abuse
MindLight, LLC 39
Early research (Phase 1)Ended earlyNCT06628622
What this trial is testing

Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine

Who this might be right for
Opioid Use Disorder
Boehringer Ingelheim 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06047834
What this trial is testing

Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids

Who this might be right for
Opioid Withdrawal (Disorder)
BioCorRx Pharmaceuticals Inc 24
Not applicableStudy completedNCT03718104
What this trial is testing

MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study

Who this might be right for
Opioid-use DisorderNeonatal Abstinence SyndromePregnancy, High Risk+1 more
Boston Medical Center 46
Testing effectiveness (Phase 2)Study completedNCT00286065
What this trial is testing

Study to Determine Efficacy and Safety of Inhaled AeroLEF in the Treatment of Acute Post-op Pain in Adult Patients Undergoing Elective Orthopedic Surgery

Who this might be right for
Pain
YM BioSciences 123
Large-scale testing (Phase 3)Study completedNCT02603705
What this trial is testing

Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain

Who this might be right for
Moderate-to-severe Chronic Noncancer Pain
Egalet Ltd 281
Early research (Phase 1)Study completedNCT00829777
What this trial is testing

Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects

Who this might be right for
Opiate Addiction
California Pacific Medical Center Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT06533657
What this trial is testing

Unique Treatment of Oncology Pain in Advanced Cancer

Who this might be right for
Cancer Pain
ZYUS Life Sciences Inc. 11
Early research (Phase 1)Study completedNCT02559973
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder

Who this might be right for
Opioid Use Disorder
Indivior Inc. 47
Post-approval studies (Phase 4)Study completedNCT01903005
What this trial is testing

Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence

Who this might be right for
Opioid Dependence, on Agonist Therapy
Orexo AB 668
Testing effectiveness (Phase 2)Study completedNCT02229929
What this trial is testing

Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus

Who this might be right for
PruritusUremic Pruritus
Cara Therapeutics, Inc. 89
Next Page